Who
Shannon T. Kelley
General Counsel
Company insider
Files Form 4 as: General Counsel, Madrigal Pharmaceuticals.
In numbers
- Trades disclosed
- 26
- Buys
- 0
- Sells
- 6
- Bought
- $0
- Sold
- $2.4M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 15 Aug 2024
- Last trade
- 17 Aug 2026
- Last filed
- 20 Aug 2026
Companies traded
Activity over time
1 Jan 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Aug 2026filed 20 Aug 2026 | MDGL Madrigal PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $342K664 at $514.97 | filing |
| 17 Aug 2026filed 20 Aug 2026 | MDGL Madrigal PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $342K664 at $514.97 | filing |
| 6 Mar 2026filed 6 Mar 2026 | MDGL Madrigal PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $155K360 at $431.94 | filing |
| 6 Mar 2026filed 6 Mar 2026 | MDGL Madrigal PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $155K360 at $431.94 | filing |
| 4 Mar 2026filed 6 Mar 2026 | MDGL Madrigal PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —4,017 at $0.00 | filing |
| 4 Mar 2026filed 6 Mar 2026 | MDGL Madrigal Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —5,022 at $0.00 | filing |
| 4 Mar 2026filed 6 Mar 2026 | MDGL Madrigal Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —5,022 at $0.00 | filing |
| 4 Mar 2026filed 6 Mar 2026 | MDGL Madrigal PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —4,017 at $0.00 | filing |
| 20 Jan 2026filed 20 Jan 2026 | MDGL Madrigal PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $129K263 at $490.77 | filing |
| 20 Jan 2026filed 20 Jan 2026 | MDGL Madrigal PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $215K429 at $501.40 | filing |
| 20 Jan 2026filed 20 Jan 2026 | MDGL Madrigal PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $129K263 at $490.77 | filing |
| 20 Jan 2026filed 20 Jan 2026 | MDGL Madrigal PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $215K429 at $501.40 | filing |
| 18 Aug 2025filed 18 Aug 2025 | MDGL Madrigal PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $164K458 at $358.66 | filing |
| 18 Aug 2025filed 18 Aug 2025 | MDGL Madrigal PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $47K126 at $369.64 | filing |
| 18 Aug 2025filed 18 Aug 2025 | MDGL Madrigal PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $31K84 at $370.06 | filing |
| 18 Aug 2025filed 18 Aug 2025 | MDGL Madrigal PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $31K84 at $371.35 | filing |
| 18 Aug 2025filed 18 Aug 2025 | MDGL Madrigal PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $94K252 at $372.44 | filing |
| 18 Aug 2025filed 18 Aug 2025 | MDGL Madrigal PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $25K68 at $374.13 | filing |
| 18 Aug 2025filed 18 Aug 2025 | MDGL Madrigal PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $71K190 at $375.75 | filing |
| 18 Aug 2025filed 18 Aug 2025 | MDGL Madrigal PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $16K42 at $376.62 | filing |
News
Head-To-Head Contrast: Zai Lab (NASDAQ:ZLAB) versus Madrigal Pharmaceuticals (NASDAQ:MDGL)MDGL · dailypolitical.com · 25 Oct 2026Comparing Madrigal Pharmaceuticals (NASDAQ:MDGL) and Incyte (NASDAQ:INCY)MDGL · themarketsdaily.com · 20 Oct 2026Madrigal Pharmaceuticals to Release Third-Quarter 2026 Financial Results and Host Webcast on November 3, 2026MDGL · manilatimes.net · 20 Oct 2026
0 headlines in the last 90 days name Shannon T. Kelley; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.